Sunshine Biopharma, Inc. SBFM
0.84
0.04
5.00%
as of 25 Sep
- Market cap
- $3.3M
- P/E
- 0.0×
Follow SBFM
Growth Flags
show if company had growth for consecutive years
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
(24.35%) | (25.69%) | (27.33%) | (21.93%) | |
| (19.47%) | (19.71%) | (21.15%) | (17.78%) | ||
ROIC |
(27.38%) | (27.97%) | (27.08%) | (26.67%) | |
Return on Tangible Assets |
(27.35%) | (28.50%) | (31.10%) | (22.85%) | |
Average Days of Receivables |
40.64 | 34.78 | 41.25 | 41.67 | |
Free Cash Flow per Share |
(17.57) | (14.84) | (13.12) | (4.06) | |
Free Cash Flow |
(8.00) | (6.17) | (6.44) | (5.54) | |
Capital Expenditures |
(0.88) | (0.84) | (0.73) | (0.18) | |
Piotroski F-Score |
2.00 | 3.00 | 3.00 | 3.00 | |
| Other line items | |||||
Cash ROIC |
(21.25%) | (16.58%) | (20.08%) | (12.97%) | |
Accounts Receivable Turnover |
10.12 | 9.91 | 9.52 | 9.27 | |
Accounts Payable Turnover |
4.86 | 4.29 | 4.70 | 5.11 | |
Inventory Turnover |
2.09 | 1.94 | 1.90 | 1.96 | |
Average Days of Payables |
89.59 | 85.96 | 78.33 | 71.89 | |
Days of Inventory on Hand |
205.30 | 204.46 | 202.06 | 179.59 | |
Tax Rate |
(0.08) | 0.00 | 0.01 | 0.00 | |
Research and Development Expense of Revenue |
1.82% | 1.66% | 1.19% | 0.67% | |
Selling, General and Administrative Expense of Revenue |
43.53% | 48.33% | 48.65% | 48.29% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.27% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
1.19 | 0.89 | 0.95 | 0.92 | |
Depreciation/Fixed assets |
3.20 | 3.73 | 4.05 | 2.17 | |
Capex/Depreciation |
(0.46) | (0.40) | (0.35) | (0.18) | |
Revenue per Share |
81.92 | 87.34 | 72.35 | 25.89 | |
Operating CF per Share |
(15.63) | (12.82) | (11.64) | (3.92) | |
Capex per Share |
(1.94) | (2.01) | (1.49) | (0.13) | |
Capex to Sales |
0.02 | 0.02 | 0.02 | 0.01 | |
Net Profit Margin |
(16.06%) | (16.46%) | (17.02%) | (16.50%) |
Columns are period end dates